Ban Zhi Lian
Scutellaria barbata D. Don
Also known as: Barbat Skullcap Herb(English) 半枝莲(Chinese)
Banjiryeon半枝蓮 반지련 Pan Chih Lien
Updated October 23, 2026 · Not yet clinically reviewed
Safety at a glance
2 recorded drug interactions
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- clearing heat
- Temperature
- Cold
- Taste
- Pungent,Bitter
- Channels
- Lung,Liver,Kidney
Functions
Clears Heat and Resolves Toxicity; Resolves Fire toxins (clove sores and toxic swellings); Invigorates Blood and Dispels Stasis; Stops Bleeding; Promotes Urination and Reduces Edema; Reduces Swelling and Alleviates Pain
Traditional uses
Ban Zhi Lian (scutellaria barbata herb) is a cold, bitter herb with a strong reputation in Chinese medicine for clearing Heat toxin, reducing swelling, and dispersing Blood stasis. It is used for toxic swellings, snake bites, carbuncles, and inflammatory conditions involving Heat toxin and Blood stasis. Modern Chinese medicine has employed it extensively in oncology-adjacent formulas, often combined with Bai Hua She She Cao, for conditions where Heat toxin and stasis are prominent features.
Western herbalism
Pharmacological effects
- Antitumor: A methanolic-extract fraction was strongly cytotoxic to K562 leukemia cells; active compound E-1-(4'-hydroxyphenyl)-but-1-en-3-one (ID50 7 ± 2 µg/ml); aqueous extract dose-dependently inhibited mutagenicity and DNA binding of AFB1, BPDE and BaP7,8-DHD.
- Immunostimulating: Polysaccharide stimulated ConA-induced murine lymphocyte transformation; i.p. 50–100 mg/kg increased DNCB delayed-type hypersensitivity in mice.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 209.
Formulas using this herb
5 of 5 formulas
- Bai Du Tang 败毒汤
- Fu Zheng Yi Yan Tang 扶正抑癌汤
- Qing Re Liang Xue Tang 清热凉血汤
- Qing Wei Tang 清胃汤
- Xiao San Tang Yi Hao 消散汤一号
Botanical
Scutellaria barbata, barbed skullcap, is a slender erect perennial herb of the family Lamiaceae native to moist grasslands, paddy margins and streamsides throughout central, southern and eastern China, Korea, Japan and parts of Southeast Asia. It produces a short, fibrous-rooted rhizome and quadrangular, sparsely pubescent stems 15-55 cm tall, branched from the base. The opposite, short-petiolate, triangular-ovate to lanceolate leaves are 1.5-3 cm long with shallowly crenate margins and a truncate to broadly cuneate base. Small bilabiate flowers 1-1.5 cm long are borne singly in the upper leaf axils, arranged in unilateral leafy racemes; the corolla is bluish-purple with the characteristic Scutellaria-typical scutellum (shield-like outgrowth) on the upper calyx lip, which enlarges and persists in fruit. The four small ovoid nutlets mature within the closed lower calyx lip. The whole flowering herb with root is harvested in summer.
- Family
- Lamiaceae
- Pharmaceutical name
- Herba Scutellariae Barbatae
- Parts used
- whole_plant
- Plant type
- herb
- Native region
- Fujian, Guangdong, Guangxi, Jiangsu, Jiangxi
Constituents
Scutellarin
Flavone glycoside · One of the principal flavonoids; a validated marker in Chinese Pharmacopoeia assays
A flavone glucuronide with antioxidant, anti-inflammatory and antiproliferative activity. In tumor models it contributes to inhibition of cell proliferation and induction of apoptosis, and is used as a quality-control marker for the herb.
Scutellarein
Flavone (aglycone) · Minor to moderate aglycone constituent
The aglycone of scutellarin; shows antioxidant and anti-tumor activity and inhibits several inflammatory mediators.
Luteolin
Flavone · Documented flavonoid constituent
Broadly studied flavone that induces apoptosis and cell-cycle arrest and downregulates matrix metalloproteinases (MMP-2/MMP-9), reducing tumor-cell invasion and migration.
Apigenin
Flavone · Present as free aglycone and glycosides (e.g., apigenin-5-O-glucoside)
Pro-apoptotic and anti-angiogenic flavone; modulates PI3K/Akt/mTOR, MAPK and NF-κB signalling in cancer-cell models.
Wogonin
Flavone · Documented flavonoid constituent
O-methylated flavone with anti-inflammatory and anticancer activity, promoting apoptosis and suppressing NF-κB-driven proliferation.
Baicalein
Flavone · Documented flavonoid constituent
Antioxidant flavone reported to inhibit tumor-cell growth and angiogenesis and to modulate immune cytokine profiles.
Scutebarbatines (e.g., scutebarbatine C, D, E)
neo-Clerodane diterpenoid alkaloids · Characteristic diterpenoid class; multiple congeners isolated
Diterpenoid alkaloids nearly unique to S. barbata; several show cytotoxicity against tumor cell lines and reversal of multidrug resistance in vitro.
Quercetin
Flavonol · Minor flavonol constituent
Antioxidant flavonol contributing to free-radical scavenging and pro-apoptotic signalling.
Drug interactions
Hepatotoxic drugs (e.g., high-dose acetaminophen, methotrexate)
Moderate · Potential additive hepatic stress · Evidence level: Theoretical
Concentrated S. barbata aqueous extract (BZL101) produced reversible transaminase elevation, including a grade 4 AST rise, in a phase 1B trial. Co-use with other hepatotoxic agents could theoretically compound liver enzyme elevation.
Clinical note: Monitor liver function if used in high doses alongside hepatotoxic medications.
Cytochrome P450 / P-gp substrate drugs
Minor · Possible altered drug levels · Evidence level: Theoretical
Flavonoids such as luteolin, apigenin, wogonin and baicalein can inhibit selected CYP isoenzymes and efflux transporters in vitro, which could theoretically alter plasma concentrations of co-administered substrate drugs.
Clinical note: Clinical significance in humans is unconfirmed; use caution with narrow-therapeutic-index drugs.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| decoction | 15–30 g | Daily | 中国药典 2020 【用法与用量】15~30g。 【性味与归经】辛、苦,寒。归肺、肝、肾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value. |
Preparations
Decoction (water extract)
Parts used: whole herb (aerial parts)
Typically 15-30 g of the dried whole herb (larger doses used in oncological support) is decocted in water. In classical practice it is combined with other heat-clearing, toxicity-resolving and blood-invigorating herbs.
Fresh herb / external application
Parts used: fresh whole herb
Fresh herb may be crushed and applied topically to sores, swellings and snakebite in traditional use, or the juice expressed and taken.
Dui yao: classical pairings
Ban Zhi Lian + Bai Hua She She Cao白花蛇舌草
Together they strengthen the clearing of heat toxin, resolving of damp and dispersing of toxic swellings beyond either alone.
Frequently used together in modern practice for toxic swellings and as adjunctive treatment in oncology.
Named pairing — Chen and Chen, Chinese Medical Herbology and Pharmacology (2004)
Evidence
Study design on record, not certainty of outcome.
- Other clinical trial
- 2
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer
Rugo H, Shtivelman E, Perez A, Vogel C, Franco S, Tan Chiu E, Melisko M, Tagliaferri M, Cohen I, Shoemaker M, Tran Z, Tripathy D · Breast Cancer Research and Treatment · 2007 · Phase 1A clinical trial (open-label)
Other clinical trial · Verified
An orally administered aqueous extract of S. barbata (BZL101) was evaluated in heavily pretreated metastatic breast cancer patients. It was well tolerated with predominantly low-grade gastrointestinal toxicity and showed early signals of disease stabilization.
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer
Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M, Shapiro CL · Breast Cancer Research and Treatment · 2010 · Phase 1B dose-escalation clinical trial (multicenter)
Other clinical trial · Verified
Twenty-seven women with metastatic breast cancer received escalating doses of BZL101 up to 40 g/day. Grade 3-4 adverse events were uncommon; the maximum tolerated dose was not reached, and 21% of patients had stable disease for more than 120 days.
Safety
Contraindications
It is not suitable for patients with blood deficiency. Its use is cautious in pregnant women.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 73–79.
Cultural and historical
Ben Cao Gang Mu Shi Yi (Supplement to the Compendium of Materia Medica), Zhao Xuemin · Qing dynasty (1765)
Guangxi / Fujian folk materia medica traditions · Traditional (documented in modern provincial herbals)
References
- Wang Y, et al.. Chemical Constituents, Anti-Tumor Mechanisms, and Clinical Application: A Comprehensive Review on Scutellaria barbata. Molecules. 2024 doi:10.3390/molecules29174134
- Gao J, Yin W, Corcoran O. From Scutellaria barbata to BZL101 in Cancer Patients: Phytochemistry, Pharmacology, and Clinical Evidence. Natural Product Communications. 2019 doi:10.1177/1934578X19880645
- Chen Q, Rahman K, Wang S, Zhou S, Zhang H. Scutellaria barbata: A Review on Chemical Constituents, Pharmacological Activities and Clinical Applications. Current Pharmaceutical Design. 2020 doi:10.2174/1381612825666191216124310